RAM
MRNA icon

Ramirez Asset Management’s Moderna MRNA Stock Holding History

Ramirez Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,000
Closed -$107K – 399
2024
Q1 		$107K Hold
1,000
– – 0.02% 268
2023
Q4 		$99.5K Hold
1,000
– – 0.02% 270
2023
Q3 		$103K Buy
+1,000
New +$112K 0.02% 258

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ramirez Asset Management's MRNA Position: Q2 2024 in Review

Ramirez Asset Management sold out of Moderna (MRNA) in Q2 2024, closing a stake of 1,000 shares — an estimated $107K sold.

Ramirez Asset Management first reported a position in MRNA in Q3 2023 and held it in 3 quarters. The position peaked at $107K in Q1 2024. 955 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Ramirez Asset Management reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Ramirez Asset Management sold 1,000 Moderna shares in Q2 2024, an estimated $107K.
  • Ramirez Asset Management first reported a position in Moderna in Q3 2023 and held it in 3 quarters.
  • Ramirez Asset Management's Moderna position peaked at $107K in Q1 2024.
  • 955 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Ramirez Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.